Category
Indian Pharma

Trump's Generic Drug Tariff Plan Sparks Concern for Indian Pharma, 200% Duty Looms After Two-Year Relief

US President Donald Trump has announced a phased tariff roadmap for imported generic medicines, keeping duties at zero for two years before imposing 100% and eventually 200% tariffs. The proposal could significantly impact India's pharmaceutical exports and force global drugmakers to rethink manufacturing strategies.
International  Trending News 
Read More...